Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline versus placebo for depressive symptoms in primary care
ISRCTN84544741Phase 4Completed
- Sponsor
- University College London
- Start
- Jan 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Sertraline with Placebo (2 arms). Primary endpoint: Depressive symptoms by PHQ-9. Started Jan 2015; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ISRCTN84544741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN84544741.